(190 days)
No
The description focuses on the material and mechanical function of a suture and delivery device, with no mention of AI or ML.
No
The device is a surgical suture and delivery device used for soft tissue approximation and/or ligation, which are procedures not inherently therapeutic on their own, but rather facilitate the body's natural healing process or repair.
No
The device is described as a surgical suture and delivery device for soft tissue approximation and/or ligation, which are therapeutic procedures, not diagnostic ones.
No
The device description clearly outlines physical components: PTFE sutures, stainless steel surgical needles, and a Suture Delivery Device (a Class I Manual Surgical Instrument). This indicates it is a hardware medical device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is for "soft tissue approximation and / or ligation" during surgical procedures. This is a direct surgical intervention on the body, not a test performed on a sample taken from the body to diagnose a condition.
- Device Description: The description details a surgical suture and a delivery device used to place the suture. This aligns with a surgical tool, not a diagnostic test.
- Lack of Diagnostic Elements: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting biomarkers, or providing diagnostic information.
- Performance Studies: The performance studies listed are mechanical and biocompatibility testing, which are relevant for surgical implants and devices, not IVDs.
IVD devices are used to examine specimens derived from the human body to provide information for the diagnosis, prevention, monitoring, treatment, or alleviation of disease. This device does not fit that description.
N/A
Intended Use / Indications for Use
The TissueStat PTFE (polytetrafluoroethylene) Suture and Delivery Device is indicated for use in all types of soft tissue approximation and / or ligation, including cardiovascular, dental, general surgical procedures and repair of the dura mater. TissueStat PTFE Sutures are not indicated for use in microsurgery, ophthalmic procedures, or peripheral neural tissues. TissueStat PTFE Sutures are provided sterile as a single use device.
Product codes
NBY
Device Description
The TissueStat PTFE surgical sutures are monofilament surgical sutures composed from expanded polytetrafluoroethylene (ePTFE) material. They are available uncoated and undyed in USP size 2/0. The sutures are attached to standard stainless steel surgical needles. The TissueStat Suture Delivery Device is a Class I Manual Surgical Instrument that assists with suture placement. The PTFE suture is loaded into the Suture Delivery Device and is delivered to the desired location through the device tip by pressing the actuation button on the device handle.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
soft tissue (including cardiovascular, dental, general surgical procedures and dura mater)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The following performance testing was conducted in support of the substantial equivalence determination.
Mechanical Testing
- Suture Diameter Testing per USP
- Suture Tensile Testing per USP
- Needle Attachment Testing per USP
Biocompatibility Testing
PTFE suture is an implant with permanent (>30days) contact with tissue. A Biocompatibility Risk Assessment was conducted in accordance with ISO 10993, Biological Evaluation of Medical Devices - Part 1: Evaluation and Testing within a Risk Management Process (2018) and the FDA Guidance "Use of International Standard ISO 10993- 1, "Biological Evaluation of Medical Devices – Part 1: Evaluation and Testing within a Risk Management Process" (2020).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.5035 Nonabsorbable expanded polytetrafluoroethylene surgical suture.
(a)
Identification. Nonabsorbable expanded polytetrafluoroethylene (ePTFE) surgical suture is a monofilament, nonabsorbable, sterile, flexible thread prepared from ePTFE and is intended for use in soft tissue approximation and ligation, including cardiovascular surgery. It may be undyed or dyed with an approved color additive and may be provided with or without an attached needle(s).(b)
Classification. Class II (special controls). The special control for this device is FDA's “Class II Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA.” See § 878.1(e) for the availability of this guidance document.
0
Image /page/0/Picture/0 description: The image contains the logos of the Department of Health and Human Services and the Food and Drug Administration (FDA). The Department of Health and Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
November 9, 2023
DuraStat LLC Adam Azzara Chief Executive Officer 1101 E 6th St Unit B Austin, Texas 78702
Re: K231277
Trade/Device Name: TissueStat Regulation Number: 21 CFR 878.5035 Regulation Name: Nonabsorbable Expanded Polytetrafluoroethylene Surgical Suture Regulatory Class: Class II Product Code: NBY Dated: May 2, 2023 Received: May 3, 2023
Dear Adam Azzara:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device"
1
(https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review. the OS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn).
2
Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/deviceadvice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Alexander Nguyen -S 2023.11.09 16:43:36 -05'00'
for Tek N. Lamichhane, Ph.D. Assistant Director DHT4B: Division of Infection Control and Plastic and Reconstructive Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
3
Indications for Use
510(k) Number (if known) K231277
Device Name
TissueStat PTFE (polytetrafluroethylene) Suture and Delivery Device
Indications for Use (Describe)
The TissueStat PTFE (polytetrafluroethylene) Suture and Delivery Device is indicated for use in all types of soft tissue approximation and / or ligation, including cardiovascular, dental, general surgical procedures and repair of the dura mater. TissueStat PTFE Sutures are not indicated for use in microsurgery, ophthalmic procedures, or peripheral neural tissues. TissueStat PTFE Sutures are provided sterile as a single use device.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| \x Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
I. SUBMITTER
DuraStat, LLC 1101 E 6th St Unit B Austin, TX USA 78702
Phone: 1 (800) 804-8018 Fax: 1 (800) 804-8018
Contact Person: Adam Azzara Date Prepared: October 26, 2023
II. DEVICE
Name of Device: TissueStat™ PTFE (polytetrafluoroethylene) Suture and Delivery Device Common or Usual Name: PTFE Nonabsorbable Surgical Sutures; Needle, Needle Guide and Knot Pusher Classification Name: Suture, Surgical, Nonabsorbable, Expanded, Polytetrafluoroethylene, 878.5035; Manual Surgical Instruments for General Use, 878.4800 Regulatory Class: II Product Code: NBY
III. PREDICATE DEVICE
DuraStat® Gazelle PTFE Suture and Delivery Device (K173335) formerly DuraTap Gazelle PTFE Suture and Delivery Device.
Reference Devices: Riverpoint Medical MonoTex ® PTFE Suture (K140415) and (K100006)
IV. DEVICE DESCRIPTION
The TissueStat PTFE surgical sutures are monofilament surgical sutures composed from expanded polytetrafluoroethylene (ePTFE) material. They are available uncoated and undyed in USP size 2/0. The sutures are attached to standard stainless steel surgical needles. The TissueStat Suture Delivery Device is a Class I Manual Surgical Instrument that assists with suture placement. The PTFE suture is loaded into the Suture Delivery Device and is delivered to the desired location through the device tip by pressing the actuation button on the device handle.
5
V. INDICATIONS FOR USE
The TissueStat PTFE (polytetrafluoroethylene) Suture and Delivery Device are indicated for use in all types of soft tissue approximation and / or ligation, including cardiovascular, dental, general surgical procedures and repair of the dura mater. TissueStat PTFE Sutures are not indicated for use in microsurgery, ophthalmic procedures, or peripheral neural tissues. TissueStat PTFE Sutures are provided sterile as a single use device.
| Attribute | Predicate
DuraStat (Gazelle)
(K173335) | Subject Device
TissueStat
(K223489) | Comparison |
|--------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|
| Manufacturer | DuraStat LLC | DuraStat LLC | Equivalent |
| Class | II | II | Equivalent |
| Product Code | NBY | NBY | Equivalent |
| Indication | The TissueStat PTFE
(polytetrafluoroethylene)
Suture and Delivery
Device are indicated for
use in all types of soft
tissue approximation and
/ or ligation, including
cardiovascular, dental,
general surgical
procedures and repair of
the dura mater.
TissueStat PTFE Sutures
are not indicated for use
in microsurgery,
ophthalmic procedures,
or peripheral neural
tissues. TissueStat PTFE
Sutures are provided
sterile as a single use
device. | The TissueStat PTFE
(polytetrafluoroethylene)
Suture and Delivery
Device are indicated for
use in all types of soft
tissue approximation and
/ or ligation, including
cardiovascular, dental,
general surgical
procedures and repair of
the dura mater.
TissueStat PTFE Sutures
are not indicated for use
in microsurgery,
ophthalmic procedures,
or peripheral neural
tissues. TissueStat PTFE
Sutures are provided
sterile as a single use
device. | Equivalent |
| Delivery Device
Materials | ABS; Delrin; Nitinol;
Stainless Steel | ABS; Delrin; Nitinol;
Stainless Steel | Equivalent |
| Suture Material | PTFE
(polytetrafluoroethylene) | PTFE
(polytetrafluoroethylene) | Equivalent |
| Suture Size | 5/0 and 6/0 | 2/0 | Different |
| Needle Material | 302 Stainless Steel | 302 Stainless Steel | Equivalent |
| Device
Characteristics | Suture delivery device
has a distal curved tip | Suture delivery device
has an elongated distal | Different |
| | with a needle and
attached suture retained
within the tip.
Depressing the Delrin
button releases the stylet
rod which deploys the
needle from the tip. | curved tip that includes a
distal brace for rigidity
with a needle and
attached suture retained
within the tip.
Depressing the primer at
the proximal end of the
device loads the spring
with a known force.
Depressing the Delrin
button releases the stylet
rod which deploys the
needle from the tip. | |
| Packaging
(Implant
contacting) | HDPE | HDPE | Same |
| Packaging (Whole
Kit) | HDPE | HDPE and PETG | Different |
| Primary Sterile
Barrier | Tyvek
(1059B)/Polyethylene
Peel Pouch. | Tyvek
(1059B)/Polyethylene
Peel Pouch. | Same |
| Sterilization
Method | Ethylene Oxide | Ethylene Oxide | Same |
| Sterilization
Assurance | 10-6 | 10-6 | Same |
| Single Use | Yes | Yes | Same |
VI. COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE PREDICATE DEVICE
6
DuraStat (formerly Gazelle) and TissueStat are both manufactured by DuraStat LLC and have similar technical characteristics and surgical use steps. The TissueStat device utilizes a larger suture, expanding the versatility of the tissue approximation technology with identical indications for use. Minor modifications to the needle and device characteristics facilitate the addition of the larger suture.
The following technological characteristics remain the same between the two devices.
- Device, suture, and needle materials
- Procedural steps and principles of operation
- Sterilization and delivery method
The following technological differences exist between the subject and predicate devices:
- Suture Size: Larger 2/0 Suture allows for approximation and/or ligation of soft tissue that ● require larger/stronger sutures with the same indications for use as the predicate.
- Needle Characteristics: Minor changes to the needle allow for approximation and/or . ligation of thicker, soft tissue with the larger 2/0 suture compared to the predicate device.
7
- Delivery Device Characteristics: The larger 2/0 suture and associated needle are accommodated by an elongated tip with a brace that allows for easy removal for the device after the suture needle is deployed. The updated button deployment enhances ergonomics while facilitating post-deployment needle/suture positioning.
- Packaging: The device's internal packaging was changed to a Tyvek lidded tray from a ● backer card to improve the appearance of the packaging and to facilitate easier device removal while providing more support to the device.
These differences do not raise new questions of safety and effectiveness and were assessed by the standardized verification and validation testing described below.
VII. PERFORMANCE DATA
The following performance testing was conducted in support of the substantial equivalence determination.
Mechanical Testing
- Suture Diameter Testing per USP ●
- . Suture Tensile Testing per USP
- Needle Attachment Testing per USP ●
Biocompatibility Testing
PTFE suture is an implant with permanent (>30days) contact with tissue. A Biocompatibility Risk Assessment was conducted in accordance with ISO 10993, Biological Evaluation of Medical Devices - Part 1: Evaluation and Testing within a Risk Management Process (2018) and the FDA Guidance "Use of International Standard ISO 10993- 1, "Biological Evaluation of Medical Devices – Part 1: Evaluation and Testing within a Risk Management Process" (2020).
VIII. CONCLUSIONS
Based on the indications for use, technological characteristics, and performance testing in comparison to the predicate device, the TissueStat PTFE Suture and Delivery Device has been shown to be substantially equivalent to the legally marketed predicate device for its intended use.